Stoke Therapeutics, Inc

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome	Epilepsies, Myoclonic, Epilepsy, Generalized, Epileptic Syndromes, brain disorder, central nervous system disorder, epilepsy, nervous system disorder	Recruiting	Phase 3	2026-08-24		NCT06872125
An Open-Label Extension Study of STK-001 for Patients With Dravet Syndrome	Epilepsies, Myoclonic, Epilepsy, Generalized, Epileptic Syndromes, brain disorder, central nervous system disorder, epilepsy, nervous system disorder	Active, not recruiting	Phase 2	2026-02-04		NCT04740476

Clinical trials